Trivalent Influenza Vaccine with Recombinant Interferon Alpha
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trivalent Influenza Vaccine with Recombinant Interferon Alpha, covering 2012-08-03 to 2012-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia [Phase 1, Phase 2]